Literature DB >> 25759925

The C342R mutation in FGFR2 causes Crouzon syndrome with elbow deformity.

Ronghu Ke1, Xianxian Yang, Cai Tianyi, Min Ge, Jiaqi Lei, Xiongzheng Mu.   

Abstract

Crouzon syndrome is an autosomal dominant craniosynostosis syndrome caused by mutation in the fibroblast growth factor receptor 2 (FGFR-2). Numerous findings from animal studies imply a critical role for FGFRs in the regulation of skeletal development. Here, we report 2 unrelated patients with Crouzon syndrome accompanied by elbow deformity. Subsequently, we analyzed the sequence of the FGFR2 gene and found that both of the patients carried the Cys342Arg mutation. The findings suggest that the C342R mutation in FGFR2 may cause Crouzon syndrome and elbow deformity in Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25759925     DOI: 10.1097/SCS.0000000000001472

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  8 in total

1.  Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.

Authors:  Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Mol Biol       Date:  2016-09-03       Impact factor: 5.469

2.  Molecular analysis of FGFR 2 and associated clinical observations in two Chinese families with Crouzon syndrome.

Authors:  Ying Lin; Hongbin Gao; Siming Ai; Jacob V P Eswarakumar; Tao Li; Bingqian Liu; Hongye Jiang; Yuhua Liu; Xialin Liu; Yonghao Li; Yao Ni; Jiangna Chen; Zhuoling Lin; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu; Yizhi Liu
Journal:  Mol Med Rep       Date:  2016-07-11       Impact factor: 2.952

Review 3.  Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis.

Authors:  Saïd C Azoury; Sashank Reddy; Vivek Shukla; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

4.  C278F mutation in FGFR2 gene causes two different types of syndromic craniosynostosis in two Chinese patients.

Authors:  Ying Lin; Hongbin Gao; Siming Ai; Jacob V P Eswarakumar; Chuan Chen; Yi Zhu; Tao Li; Bingqian Liu; Xialin Liu; Lixia Luo; Hongye Jiang; Yonghao Li; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu
Journal:  Mol Med Rep       Date:  2017-08-14       Impact factor: 2.952

5.  Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome.

Authors:  Anh Lan Thi Luong; Thuong Thi Ho; Ha Hoang; Trung Quang Nguyen; Tu Cam Ho; Phan Duc Tran; Thuy Thi Hoang; Nam Trung Nguyen; Hoang Ha Chu
Journal:  Biomed Rep       Date:  2019-01-03

6.  Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2.

Authors:  Meina Lin; Yongping Lu; Yu Sui; Ning Zhao; Ying Jin; Dongxu Yi; Miao Jiang
Journal:  Mol Genet Genomic Med       Date:  2019-07-18       Impact factor: 2.183

7.  Clinical assessment and FGFR2 mutation analysis in a Chinese family with Crouzon syndrome: A case report.

Authors:  Huijun Shi; Jie Yang; Qingmin Guo; Minglian Zhang
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

8.  FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome.

Authors:  Ying Lin; Hongbin Gao; Siming Ai; Jacob V P Eswarakumar; Yi Zhu; Chuan Chen; Tao Li; Bingqian Liu; Hongye Jiang; Yuhua Liu; Yonghao Li; Qingxiu Wu; Haichun Li; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu
Journal:  Mol Med Rep       Date:  2017-08-29       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.